These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 22584902

  • 21. Acute pancreatitis caused by bortezomib.
    Solakoglu T, Akyol P, Guney T, Dilek I, Atalay R, Koseoglu H, Akin E, Demirezer Bolat A, Buyukasik NS, Ersoy O.
    Pancreatology; 2013; 13(2):189-90. PubMed ID: 23561979
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma.
    Ozkurt ZN, Sucak GT, Aki SZ, Yağci M, Erdem O.
    Cutan Ocul Toxicol; 2009; 28(3):141-3. PubMed ID: 19548772
    [Abstract] [Full Text] [Related]

  • 24. Hyperlipidemia in a myeloma patient after bortezomib treatment.
    Gozzetti A, Fabbri A, Defina M, Chitarrelli I, Bocchia M.
    Leuk Res; 2010 Sep; 34(9):e250. PubMed ID: 20363499
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Optimizing bortezomib treatment in patients with relapsed multiple myeloma.
    Richardson P.
    Clin Adv Hematol Oncol; 2006 May; 4(5):4-5; discussion 8; suppl 13. PubMed ID: 16832859
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Herpesviral encephalitis associated with bortezomib use in a patient with multiple myeloma and associated light-chain amyloidosis.
    Garrido D, Riva E.
    J Oncol Pharm Pract; 2022 Oct; 28(7):1659-1663. PubMed ID: 35119328
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B.
    Goldberg R, Smith E, Bell S, Thompson A, Desmond PV.
    Intern Med J; 2013 Jul; 43(7):835-6. PubMed ID: 23841765
    [No Abstract] [Full Text] [Related]

  • 31. Severe acute enteritis in a multiple myeloma patient receiving bortezomib and spinal radiotherapy: case report.
    Mohiuddin MM, Harmon DC, Delaney TF.
    J Chemother; 2005 Jun; 17(3):343-6. PubMed ID: 16038531
    [Abstract] [Full Text] [Related]

  • 32. Bortezomib in multiple myeloma.
    Mateos MV, San Miguel JF.
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):701-15. PubMed ID: 18070714
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice.
    Wu KL, van Wieringen W, Vellenga E, Zweegman S, Lokhorst HM, Sonneveld P.
    Haematologica; 2005 Jul; 90(7):996-7. PubMed ID: 15996946
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bortezomib for myeloma -- much ado about something.
    Dispenzieri A.
    N Engl J Med; 2005 Jun 16; 352(24):2546-8. PubMed ID: 15958811
    [No Abstract] [Full Text] [Related]

  • 37. Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case report.
    Tanaka H, Sakuma I, Hashimoto S, Takeda Y, Sakai S, Takagi T, Shimura T, Nakaseko C.
    J Clin Exp Hematop; 2012 Jun 16; 52(1):67-9. PubMed ID: 22706534
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Optimizing the efficacy and safety of bortezomib in relapsed multiple myeloma.
    Richardson P, Jagannath S, Colson K.
    Clin Adv Hematol Oncol; 2006 May 16; 4(5):1; discussion 8; suppl 13. PubMed ID: 16830422
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.